This company also advertises a Wolverine Nasal Spray to treat arthritis
This matters for immunity because: Chronic inflammation diverts immune resources away from pathogen defense Excessive inflammatory signaling can cause immunosuppression over time Balanced inflammation supports both innate and adaptive immune responses Limitations and Context AOD-9604 isn't a targeted immune therapy Direct immune function studies are limited For targeted immune support, peptides like Thymosin Alpha-1 have stronger evidence Thymosin Alpha-1 benefits Standard immune health practices (sleep, nutrition, stress management) remain the foundation Frequently Asked Questions Is AOD-9604 right for me
Rising hunger, waist growth, weight gain above about 2 lb per month, persistent heart-rate elevation, or declining strength indicate that the lower dose is not maintaining the prior response
Here's how they compare: Peptide Primary research area FDA status Advisory committee review BPC-157 Tissue repair, angiogenesis Not approved Yes (free base + acetate) TB-500 Actin regulation, cell migration Not approved Yes MOTS-c Mitochondrial metabolism Not approved Yes KPV Anti-inflammatory Not approved Yes GHK-Cu Copper-peptide skin/healing Not approved Not on 2026 agenda For a deeper comparison of BPC-157 and its most-researched counterpart, see our BPC-157 vs TB-500 research comparison
It is a type of megaloblastic anemia caused by defective DNA synthesis
